Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
Public ClinicalTrials.gov record NCT00160342. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Blind, Placebo-Controlled Comparison of Multiple Doses of Esterified Estrogens and Methyltestosterone, in Combination and Alone, in Relieving Vasomotor Symptoms in Postmenopausal Women
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a research study to evaluate the effectiveness, safety and side effects of several dose levels of esterified estrogens (EE) and methyltestosterone (MT) given individually and in combination compared to a placebo (a tablet with no active drug in it) as a possible treatment for vasomotor symptoms (such as hot flushes and flushing) of menopause. EE and testosterone are two hormones which are typically deficient in menopausal women
Study identification
- NCT ID
- NCT00160342
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1,251 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2005 (Type not available)
- Primary completion
- Sep 2007 (Actual)
- Completion
- Sep 2007 (Actual)
- Last update posted
- Aug 15, 2008
2005 – 2007
United States locations
- U.S. sites
- 88
- U.S. states
- 31
- U.S. cities
- 72
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 37 | Montgomery | Alabama | — | — |
| Site 69 | Montgomery | Alabama | — | — |
| Site 44 | Tucson | Arizona | — | — |
| Site 6 | Jonesboro | Arkansas | — | — |
| Site 62 | Little Rock | Arkansas | — | — |
| Site 70 | Carmichael | California | — | — |
| Site 85 | Carmichael | California | — | — |
| Site 87 | Northridge | California | — | — |
| Site 18 | San Diego | California | — | — |
| Site 27 | San Diego | California | — | — |
| Site 54 | San Diego | California | — | — |
| Site 31 | Vista | California | — | — |
| Site 68 | Walnut Creek | California | — | — |
| Site 66 | Denver | Colorado | — | — |
| Site 4 | Groton | Connecticut | — | — |
| Site 35 | New Britain | Connecticut | — | — |
| Site 14 | Waterbury | Connecticut | — | — |
| Site 25 | Aventura | Florida | — | — |
| Site 26 | Aventura | Florida | — | — |
| Site 51 | Clearwater | Florida | — | — |
| Site 71 | Clearwater | Florida | — | — |
| Site 61 | Daytona Beach | Florida | — | — |
| Site 75 | Gainesville | Florida | — | — |
| Site 33 | Pensacola | Florida | — | — |
| Site 21 | Stuart | Florida | — | — |
| Site 82 | Tampa | Florida | — | — |
| Site 9 | Venice | Florida | — | — |
| Site 83 | West Palm Beach | Florida | — | — |
| Site 40 | Alpharetta | Georgia | — | — |
| Site 90 | Alpharetta | Georgia | — | — |
| Site 23 | Atlanta | Georgia | — | — |
| Site 8 | Atlanta | Georgia | — | — |
| Site 60 | Powder Springs | Georgia | — | — |
| Site 55 | Savannah | Georgia | — | — |
| Site 76 | Boise | Idaho | — | — |
| Site 64 | Champaign | Illinois | — | — |
| Site 58 | Chicago | Illinois | — | — |
| Site 72 | Chicago | Illinois | — | — |
| Site 74 | Chicago | Illinois | — | — |
| Site 50 | Evansville | Indiana | — | — |
| Site 52 | Baton Rouge | Louisiana | — | — |
| Site 65 | Mandeville | Louisiana | — | — |
| Site 73 | Metarie | Louisiana | — | — |
| Site 15 | Lutherville | Maryland | — | — |
| Site 43 | Ann Arbor | Michigan | — | — |
| Site 12 | Chaska | Minnesota | — | — |
| Site 80 | Chesterfield | Missouri | — | — |
| Site 16 | Kansas City | Missouri | — | — |
| Site 19 | Kansas City | Missouri | — | — |
| Site 3 | St Louis | Missouri | — | — |
| Site 17 | Billings | Montana | — | — |
| Site 36 | Lincoln | Nebraska | — | — |
| Site 7 | Las Vegas | Nevada | — | — |
| Site 28 | Reno | Nevada | — | — |
| Site 39 | New Bern | North Carolina | — | — |
| Site 79 | Raleigh | North Carolina | — | — |
| Site 46 | Winston-Salem | North Carolina | — | — |
| Site 59 | Winston-Salem | North Carolina | — | — |
| Site 45 | Cincinnati | Ohio | — | — |
| Site 81 | Cincinnati | Ohio | — | — |
| Site 53 | Columbus | Ohio | — | — |
| Site 34 | Mayfield Heights | Ohio | — | — |
| Site 78 | Mogadore | Ohio | — | — |
| Site 77 | Tulsa | Oklahoma | — | — |
| Site 13 | Portland | Oregon | — | — |
| Site 89 | Portland | Oregon | — | — |
| Site 84 | Philadelphia | Pennsylvania | — | — |
| Site 63 | Pottstown | Pennsylvania | — | — |
| Site 22 | Warwick | Rhode Island | — | — |
| Site 24 | Greenville | South Carolina | — | — |
| Site 67 | Hilton Head | South Carolina | — | — |
| Site 10 | Chattanooga | Tennessee | — | — |
| Site 88 | Memphis | Tennessee | — | — |
| Site 56 | Nashville | Tennessee | — | — |
| Site 86 | Bryan | Texas | — | — |
| Site 20 | Corpus Christi | Texas | — | — |
| Site 11 | Houston | Texas | — | — |
| Site 30 | San Antonio | Texas | — | — |
| Site 41 | San Antonio | Texas | — | — |
| Site 49 | Salt Lake City | Utah | — | — |
| Site 47 | Charlottesville | Virginia | — | — |
| Site 2 | Norfolk | Virginia | — | — |
| Site 29 | Richmond | Virginia | — | — |
| Site 48 | Richmond | Virginia | — | — |
| Site 42 | Virginia Beach | Virginia | — | — |
| Site 5 | Seattle | Washington | — | — |
| Site 38 | Spokane | Washington | — | — |
| Site 32 | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00160342, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2008 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00160342 live on ClinicalTrials.gov.